Wave Life Sciences Ltd. (WVE) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Wave Life Sciences Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.800 Hello and welcome to Wavelife Science, the second quarter 2025 earnings call. 00:00:04.800 -- 00:00:08.420 We ask that you please hold all questions until the completion of the formal remarks, 00:00:08.420 -- 00:00:13.300 at which time you will be given instructions for the question and answer session. 00:00:13.300 -- 00:00:16.480 Also as a reminder, this conference is being recorded today. 00:00:16.480 -- 00:00:20.520 I will now pass the call over to Kate Rausch, Vice President of Corporate Affairs and 00:00:20.520 -- 00:00:22.900 Investor Relations. 00:00:23.740 -- 00:00:26.500 Thank you, operator. And good morning to everyone on the call. 00:00:26.500 -- 00:00:31.000 Earlier this morning, we issued a press release outlining our second quarter 2025 earnings 00:00:31.000 -- 00:00:34.140 update. Joining me today with prepared remarks are Dr. 00:00:34.140 -- 00:00:37.300 Paul Polno, President and Chief Executive Officer, Dr. 00:00:37.300 -- 00:00:42.600 Eric Ingelson, Chief Scientific Officer, and Kyle Moran, Chief Financial Officer. 00:00:42.600 -- 00:00:46.560 Dr. Chris Wright, Chief Medical Officer is also in the room and will be available for 00:00:46.560 -- 00:00:50.480 questions. The press release issued this morning is available on the investor section 00:00:50.480 -- 00:00:53.400 of our website, .wavelifesciences.com. 00:00:55.160 -- 00:00:58.220 Before we begin, I would like to remind you that discussions during this conference call 00:00:58.220 -- 00:01:01.960 will include forward-looking statements. These statements are subject to several risks 00:01:01.960 -- 00:01:05.640 and uncertainties that could cause our actual results to differ materially from those 00:01:05.640 -- 00:01:07.680 described in these forward-looking s...